GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » Other Long-Term Liabilities

Hanmi Pharm Co (XKRX:128940) Other Long-Term Liabilities : ₩3,503 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Hanmi Pharm Co Other Long-Term Liabilities?

Hanmi Pharm Co's other long-term liabilities for the quarter that ended in Sep. 2024 was ₩3,503 Mil.

Hanmi Pharm Co's quarterly other long-term liabilities declined from Mar. 2024 (₩4,841 Mil) to Jun. 2024 (₩4,377 Mil) and declined from Jun. 2024 (₩4,377 Mil) to Sep. 2024 (₩3,503 Mil).

Hanmi Pharm Co's annual other long-term liabilities declined from Dec. 2021 (₩49,405 Mil) to Dec. 2022 (₩12,795 Mil) and declined from Dec. 2022 (₩12,795 Mil) to Dec. 2023 (₩4,603 Mil).

Hanmi Pharm Co Other Long-Term Liabilities Historical Data

The historical data trend for Hanmi Pharm Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Pharm Co Other Long-Term Liabilities Chart

Hanmi Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hanmi Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hanmi Pharm Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Hanmi Pharm Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Hanmi Pharm Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanmi Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » Other Long-Term Liabilities
Comparable Companies
XKRX:000100 XKRX:068760 XKRX:009420 XKRX:000250 XKRX:237690 XKRX:195940 XKRX:069620 XKRX:185750 XKRX:006280 XKRX:086450 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
45 Bangi-dong, Songpa, Seoul, Gyeonggi, KOR, 138-724
Website
http://www.hanmi.co.kr
Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.

Hanmi Pharm Co Headlines

No Headlines